Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 1151 - 1200 of 1560
Formation of Herd Immunity to SARS-CoV-2 in the Regions of Uzbekistan
GHDx Entry last modified on: Oct 13, 2023
SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020
GHDx Entry last modified on: Mar 14, 2022
Is Karachi Knocking at Herd Immunity? A Possible Reason for Decline in SARS-CoV-2 Infections. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
GHDx Entry last modified on: Mar 14, 2022
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
GHDx Entry last modified on: Mar 14, 2022
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
GHDx Entry last modified on: May 12, 2022
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort - EPICOV. Preprint
GHDx Entry last modified on: May 12, 2022
Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities
GHDx Entry last modified on: May 12, 2022
Childbirth Care among SARS-CoV-2 Positive Women in Italy
GHDx Entry last modified on: Apr 10, 2023
Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Nonpregnant Women in Osaka, Japan
GHDx Entry last modified on: Apr 10, 2023
Exploring Pregnancy Outcomes Associated with SARS-CoV-2 Infection
GHDx Entry last modified on: Apr 10, 2023
Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological study
GHDx Entry last modified on: Apr 10, 2023
Coronavirus disease 2019 pregnancy outcomes in a racially and ethnically diverse population
GHDx Entry last modified on: Apr 10, 2023
Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany
GHDx Entry last modified on: Apr 10, 2023
Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes
GHDx Entry last modified on: Dec 12, 2023
Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital
GHDx Entry last modified on: Mar 22, 2024
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors
GHDx Entry last modified on: Mar 22, 2024
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
GHDx Entry last modified on: Mar 22, 2024
Post-COVID-19 syndrome and humoral response association after 1year in vaccinated and unvaccinated patients
GHDx Entry last modified on: Mar 22, 2024
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study
GHDx Entry last modified on: Mar 22, 2024
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria
GHDx Entry last modified on: Mar 14, 2022
IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea
GHDx Entry last modified on: Dec 19, 2023
Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak
GHDx Entry last modified on: Mar 14, 2022
Diet and physical activity during the COVID-19 lockdown period (March-May 2020): results from the French NutriNet-Santé cohort study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris
GHDx Entry last modified on: Nov 11, 2024
A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society
GHDx Entry last modified on: Mar 14, 2022
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020
GHDx Entry last modified on: Mar 14, 2022
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
GHDx Entry last modified on: Apr 10, 2023
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
GHDx Entry last modified on: Apr 10, 2023
Dominican Republic Weekly Epidemiological Bulletin 2021
Boletín Epidemiológico Semanal 2021
Epi surveillance:
Subnationally representative
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia. Preprint
GHDx Entry last modified on: Jun 17, 2021
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
GHDx Entry last modified on: Jan 31, 2024
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
GHDx Entry last modified on: Jan 31, 2024
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
GHDx Entry last modified on: Mar 14, 2022
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
GHDx Entry last modified on: May 12, 2022
Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran
GHDx Entry last modified on: Mar 14, 2022
Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands
GHDx Entry last modified on: May 12, 2022
Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad
GHDx Entry last modified on: Jan 31, 2024
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
GHDx Entry last modified on: Apr 10, 2023
Subscribe